CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award CEO & Co. Chairman acquired 140,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,500 shares (grant or award)
- 4 Grant or award Director acquired 5,500 shares (grant or award)
- 4 Grant or award Director acquired 5,500 shares (grant or award)
- 4 Grant or award Director acquired 5,500 shares (grant or award)
- 4 Grant or award CEO & Co. Chairman acquired 138,536 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 45,000 shares (grant or award)
- 4 Grant or award Director acquired 37,500 shares (grant or award)
- 4 Grant or award Director acquired 5,500 shares (grant or award)
- 4 Open-market buy Director bought 2,500 shares at $1.98 ($4,950)
Page 15 of 18 · 352 filings